Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling
Matrix Biology · 2024
DOI: 10.1016/j.matbio.2024.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Matrix Biology, 2024. Verfasst von Cassandre Labelle-Dumais und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA. Hauptthemen laut MEDLINE: Collagen Type IV, Signal Transduction, Disease Models, Animal, Transforming Growth Factor beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NEI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Skeletal defects are hallmark features of many extracellular matrix (ECM) and collagen-related disorders. However, a biological function in bone has never been defined for the highly evolutionarily conserved type IV collagen. Collagen type IV alpha 1 (COL4A1) and alpha 2 (COL4A2) form α1α1α2 (IV) heterotrimers that represent a fundamental basement membrane constituent present in every organ of the body, including the skeleton. COL4A1 and COL4A2 mutations cause Gould syndrome, a variable and clinically heterogenous multisystem disorder generally characterized by the presence of cerebrovascular disease with ocular, renal, and muscular manifestations. We have previously identified elevated TGFβ signaling as a pathological insult resulting from Col4a1 mutations and demonstrated that reducing TGFβ signaling ameliorate ocular and cerebrovascular phenotypes in Col4a1 mutant mouse models of Gould syndrome. In this study, we describe the first characterization of skeletal defects in Col4a1 mutant mice that include a developmental delay in osteogenesis and structural, biomechanical and vascular alterations of mature bones. Using distinct mouse models, we show that allelic heterogeneity influences the presentation of skeletal pathology resulting from Col4a1 mutations. Importantly, we found that TGFβ target gene expression is elevated in developing bones from Col4a1 mutant mice and show that genetically reducing TGFβ signaling partially ameliorates skeletal manifestations. Collectively, these findings identify a novel and unsuspected role for type IV collagen in bone biology, expand the spectrum of manifestations associated with Gould syndrome to include skeletal abnormalities, and implicate elevated TGFβ signaling in skeletal pathogenesis in Col4a1 mutant mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA.
- Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA, 94143, USA; UC Berkeley/UCSF Graduate Program in Bioengineering, San Francisco, CA 94143, USA.
- Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA, 94143, USA.
- Department of Mechanical and Aerospace Engineering, University of California San Diego, San Diego, CA 92093, USA.
- Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA, 94143, USA; Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA; Department of Mechani…
- Departments of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA; Department of Anatomy, Institute for Human Genetics, Bakar Aging Research Institute, and Cardiovascular Research Instit…
Förderung
- NIAMS NIH HHS
- NEI NIH HHS
- NINDS NIH HHS
- Research to Prevent Blindness
- Center for Evolutionary Biology and Medicine, University of Pittsburgh
- NIH
- National Eye Institute
Zitieren
APA
Labelle-Dumais, C., Mazur, C., Kaya, S., Obata, Y., Lee, B., Acevedo, C., Alliston, T., & Gould, D. B. (2024). Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling. Matrix Biology. https://doi.org/10.1016/j.matbio.2024.07.005
Vancouver
Labelle-Dumais C, Mazur C, Kaya S, Obata Y, Lee B, Acevedo C, et al. Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling. Matrix Biology. 2024. doi:10.1016/j.matbio.2024.07.005
BibTeX
@article{LabelleDumais2024,
author = {Labelle-Dumais, Cassandre and Mazur, Courtney and Kaya, Serra and Obata, Yoshihiro and Lee, Bryson and Acevedo, Claire and Alliston, Tamara and Gould, Douglas B},
title = {Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling},
journal = {Matrix Biology},
year = {2024},
doi = {10.1016/j.matbio.2024.07.005}
}
EUVIMED